Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center has participated in 3 clinical trials.
Therapeutic areas: Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer.
Sponsors: SCRI Development Innovations, LLC.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center has 3 clinical trials on record. Their work covers Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer.
Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.